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Degradation of (-)-a-narcotine (5), (-)-ß-narcotine (6), and (->ß-hydrastine 
(7) with ethyl chloroformate (ECF) affords the chloro-urethans 9 and 18, 
respectively. Diastereomer 9-1 is easily hydrolyzed to the hydroxy-urethan 
10, whilst 18 is converted to the methoxy-analogue 19. The stiibene lactone 
11 is obtained from 9-1 by treatment with DBU, the analogous stiibene 17 
arises already when 7 is reacted with ECF. - Hydroxy-urethan 10 - a pheny-
logous aldol - is split by OH" to aldehyde 13 and to meconine (14). U A I H 4 -
reduction of 10 yields the stereochemically homogenous triol 15, which is 
cyclized to diastereomers of the 3-phenyl-isochroman 16 under acidic condi-
tions. 
Ringöffnung von Phthalidisochinolin-Alkaloiden durch Chlorameisen-
säureethylester 
Der Abbau von (-)-a-Narkotin (5), (-)-ß-Narkotin (6) und (-)-ß-Hydrastin (7) 
mit Chlorameisensäureethylester (ECF) fuhrt zu den Chlorurethanen 9 bzw. 
18. Das Diastereomer 9-1 reagiert leicht zum Hydroxyurethan 10, 18 zum 
Methoxy-Analogen 19. Chlorurethan 9-1 bildet mit DBU das Stilbenlacton 
11, aus 7 entsteht das analoge Stilben 17 bereits beim ECF-Abbau. - Hy-
droxyurethan 10 (ein phenyloges Aldol) wird durch Basen zum Aldehyd 13 
und Mekonin (14) gespalten. UAIH4 reduziert 10 zum Stensen einheitlichen 
Triol 15, das H+-katalysiert zu Diastereomeren des 3-Phenylisochromans 16 
zyklisiert wird. 
Gadamer and Knochl) have introduced ethyl chloroformate (ECF) for the 
benzylic cleavage of N-alkylated 1,2,3,4-tetrahydroisoquinolines; von 
Bruchhausen and Knabe2) have overcome the obstacle1* that the urethan 
moiety so obtained could not be hydrolyzed to the corresponding secondary 
amine by reducing the carbamate with L i A l H 4 , and Knabe and ShuklcP 
have studied the electronic requirements for the cleavage of benzylamines 
in general. Some more aspects of von Bruchhausen's experiments are com-
piled in a review4). 
We have repeated5* Gadamer's experiments with laudanosine (1) and 
isolated the chloro-urethan 2, the intermediate in the formation of stiibene 
3 from laudanosine ( l ) l ' 2 ) as postulated by Godamed. Neither the absolute 
configuration nor the optical purity of chloro-urethan 2 could be deter-
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mined up to now (vide infra). The hydroxy-urethan 4 was obtained from 2 
by hydrolysis or under more vigorous conditions with ECF from 1 with a 
47:53-ratio of enantiomers5). 
These findings prompted us to study the degradation of 
a-narcotine (5), ß-narcotine (6), and ß-hydrastine (7); these 
alkaloids are characterized by an additional centre of chir-
ality in their lactone parts (C-9), in direct neighbourhood of 
the chiral centre under consideration. 
A similar reaction has been performed with (-)-a-5 and (+)-ß-narcotine 
(6), respectively, by Kerekes, Gaäl, et al. 6 ) using BrCN: under solvolytic 
conditions they obtained the same hydroxylated cyanamide 8 from (-)-5 
and (+)-6. X-ray analysis of 8 obtained from (+)-ß-narcotine ((+)-6, 15, 
9S) revealed lS,9S-configuration for this "N-cyano-1 -hydroxy- 1,2-seco-
narcotine" (8)7). The authors discuss the stereochemical course of their 
reactions .6) 
BrCN 
( - ) -5 or (+)-6 
We used Gadamer's conditions (ECF; CHC1 3 /Et 2 0 1:1-
vol.; 15% K O H ) 1 } for the cleavage of (-)-oc-narcotine (5) 
and obtained a rather stable chlorine containing compound 
with an urethan- (1695 cm"1) and a five-membered lactone-
(1760 cm"1) absorption in its IR-spectrum. The ! H - N M R -
spectrum revealed an ethyl increment, the N-CH3 singlet of 
the former a-narcotine (5) now resonated at lower field 
strength (cf. Experim. Part). These data are in agreement 
with structure 9. - HPLC-analysis (Si0 2 ; CH 2 Cl2 /E t 2 0 1:4) 
showed that the reaction is highly stereoselective producing 
the diastereomeric urethans 9 in a 93:7 ratio, with [a]^ > = 
-8° (CHCI3) for the main product (9-1). We tried to convert 
9-1 into 9-minor product (9-H) under the conditions de-
scribed in Table 1, but - with the exception of entry 6- 9-1 
was recovered with the optical rotation unchanged. 
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Table 1: Stereochemical Stability of Urethan 9-1. Chloro-urethan 9-1 was 
treated under the conditions cited, the mixtures were analyzed by HPLC 
(cf. Experim. Part), rotations were measured directly (no work-up*0). 
Entry Conditions Results Rotation 
1 acetone absol.; r.t. a b 
2 Nal; acetone absol.; r.t. a b 
3 LiCl; 1,2-dimethoxyethane absol.; 
r t 
a b 
4 
r.i. 
LiCl + A1C13; 1,2-dimethoxyethane a b 
absol.; r.t 
5 Nal; 1,2-dimethoxyethane; r.t. a b 
6 Nal; acetone absol.; reflux c d 
a: no reaction 
b: rotation unchanged 
c: formation of stiibene 11 
d: rotation zero (see c) 
*} Work-up affords carbinol 10 
Heating the chloro-urethan 9-1 with water or treatment 
with moist A g 2 0 in dioxan produced the hydroxy-urethan 
10. In the meantime Lee et a l . 8 ) have prepared this com-
pound by a different procedure and have established its 
stereochemistry (aS,9S) by X-ray analysis. Compound 10 is 
also obtained on prolonged reaction of a-narcotine (5) with 
E C F / K O H in CHC1 3 /Et 2 0. - Treatment of the hydroxy-ure-
than 10 with S O C l 2 regenerated the chloro-urethan 9-1 
([a]2S = -8°(CHCl 3 )) . 
Calculations using the molecular-modelling program 
S Y B Y L (TRIPOS) indicate that a decision concerning the 
stereochemistry of the ECF-cleavage products 9 to be based 
on ^ - N M R data is scarcely possible: two conformations 
nearly equal in energy exist for the product of inversion (a-S) 
as well as for the compound produced by retention (a-R). 
Both diastereomers show two energetically favoured confor-
mations, characterized by torsion angles of 52° and 180°, re-
spectively, formed by the H-atoms at C -a and the phthalid-C. 
Both diastereomers can adopt conformations with the 
meta-H of the phthalid increment located over the second 
aromatic group, and according to the !H-NMR-spectra such 
an arrangement might exist*** 
When 9-1 was heated with l,8-diazabicyclo[5.4.0]un-
decene-7 (DBU) the stiibene 11 arose, characterized by the 
absorption of the enol-lactone at 1775 c m 1 , the NT" at m/z 
485 and the cleavage of the stiibene double-bond under EI-
conditions9 ). The resonance of the vinylic H at 8 = 6.51 ppm 
points towards fra^s-configuration (increment calculations10* 
result in 8 (ppm) = 6.13 for eis- and 6.33 for trans-configu-
ration, respectively). 
When (-)-ß-narcotine (6) (IR,9R) was treated analogously 
to a-narcotine (5) two chloro-urethans 9-III and 9-IV arose 
in a 1:1 ratio. 9-ÜI shows [a]2?, = -7.5° (CHC1 3); the 100 
MHz^H-NMR-spectrum of chloro-urethan 9-IV (m.p. 
120°C, [a] 2^ = +7°) (CHC1 3) is identical with the main ure-
than 9-1 from a-narcotine (5) (m.p. 118°C, [afi = -8°) 
(CHCI3), indicating that 9-IV and 9-1 are enantiomers. 
Fig. 1: Energetically favoured conformations a and b for 9-1 following ECF-degradation of 5 either with retention or 
inversion. 
' The Figures were plotted using ALCHEMY II (TRIPOS) program, the torsion angles were calculated with SYBYL and transfered. The conformations of 
the side chain and the methoxy groups were not fitted perfectly, because they do not affect the stereochemistry of the centers of chirality. 
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We tried to convert the 5-ring lactone of 10 into the 6-ring 
lactone of the 3-phenyl-isochroman-l-one 12 under basic 
conditions in order to determine the absol. configuration of 
the carbinol chiral center in 10 (intramolecular transesterifi-
cation). These experiments failed: compound 10 was split to 
the aldehyde 13 and to meconine (14) because compound 10 
is a phenylogous ß-hydroxyketone sustaining aldol-cleav-
age. - When purified 10 was reduced by L i A l H t to the triol 
15, which is homogenous according to its ^ -NMR-spec-
trum, followed by H+-catalyzed ring closure to the 4-hy-
droxy-3-phenylisochroman 16, a 3:1 mixture of diastereo-
mers arose. Therefore, this experiment does not indicate the 
absolute configuration at C-3 in 16 and - consequently - at 
the carbinol chiral centre of the hydroxy-urethan 10. 
In the course of a-narcotine (S)-cleavage a hypothetic 
quarternary urethan >N +(CH 3)-CO-OEt is converted by ex-
ternal CI" to the chloro-urethans, e.g. 9 (a quaternary urethan 
is an intermediate in the ECF-cleavage reaction of C-l-un-
substituted iV-methyl-l,2,3,4-tetrahydroisoquinolinesn)). 
This may occur by inversion, retention or via a resonance-
stabilized carbenium ion, followed by nucleophilic substitu-
tion under asymmetric induction exerted by the chiral centre 
at the lactone group. - In order to have an intramolecular nu-
cleophile available, a-narcotine (5) was converted to its so-
dium salt 1 2 ), which was treated with E C F / K O H . We isolated 
a mixture of 9 and 10. Treatment of this sodium salt in the 
bomb tube led to 10 (main product) besides some 9. - E C F is 
known to activate carboxylate ions by conversion to mixed 
anhydrides13). Probably an analogous reaction regenerated 
the lactone of a-narcotine (5) which is cleaved by E C F (vide 
supra). When we tried to prevent this lactonization by treat-
ment of the benzylic OH-group in a-narcotine sodium salt 
with CH2N2/BF3, or dimethyl sulfate under phase transfer 
conditions14*, or with dihydropyran 1 5 ) we obtained a-narco-
tine (5), identical with authentic material. Formation of ß-
narcotine (6) was excluded by the ^-NMR-spectrum. 
Cleavage of(-)-fi-hydrastine (7) with ECF 
(-)-ß-Hydrastine (7) was treated with E C F as described for 
a-narcotine (5), leading to two products. One compound 
reveals an enol-lactone absorption at 1775 cm"1 and shows 
an intensive bluish fluorescence. Its UV-spectrum (A, max = 
378 nm) is comparable with that of the analogous com-
pound obtained by Klötzerl6) who degraded ß-hydrastine (7) 
with phenyl chloroformate/diisopropyl-ethylamine (k max = 
385 nm). Our analytical data (cf. Experim. Part) are in ac-
cordance with structure 17. Because Klötzer1® has con-
firmed Z-configuration for his compound by X-ray analysis, 
17 is also a frans-stilbene. HPLC-analysis of the mother 
liquors of 17 indicated a 4:1-mixture of a second compound 
- [18] - with 17; this mixture could not be separated (vide 
infra). According to Beilstein1 s test and to its M S 18 con-
tains chlorine. M + " of 18 looses H C l to m/z 455, which 
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decomposes to m/z 352 (McLqfferty). For further fragments 
cf. Experim. Part. - When we tried to separate 18 from 17 by 
H P L C , using MeOH/ water 3:1, 18 was converted to the 
methoxy-analogue 19. 
Contrary to our results, Whaleyll) has obtained meconine (14) and N-car-
bethoxy-hydrastinine from ß-hydrastine (7) with ECF, probably due to his 
more vigorous conditions during work-up. These may have led to an aldol-
cleavage analogous to that mentioned with the hydroxy-urethan 10. - Olof-
son et al . 1 8 ) , however, obtained an enol lactone, analogous with 17, when 
treating 7 with vinyl chloroformate. 
Experimental Part 
General Remarks: Melting points: Büchi 510 apparatus, uncorrected.-
Elemental analyses: Mikroanalytisches Laboratorium, University of Re-
gensburg.- IR-spectra: Beckman Acculab 3; KBr.- *H-NMR: Varian EM 
360 W, Varian E M 390, CDC13, TMS as internal standard, 60 MHz, if not 
stated otherwise.- UV-spectra: Uvikon 810, Kontron.- Mass spectra: Varian 
MAT CH5 und 311 A. 
ECF-degradation of a-narcotine (5): 3-{[2-($-N-Ethoxycarbonyl-
N-methyl-aminoethyl)-6-methoxy-4j-methylenedioxyphenyl]-chloro-
methyl} -6,7-dimethoxy-l (3H)-isobenzqfuranone (9-1) 
0.41 g (1 mmole) of a-narcotine (5) in 5 ml of CHCl3 /E t 2 0 were shaken 
with 5 ml of 15% KOH and 0.8 ml of ethyl chloroformate (ECF) for 2 h at 
room temp. This procedure was repeated, followed by shaking with 2.5 ml 
of KOH for 1 h and standing overnight. The combined org. phases were 
extracted with N HCl, washed with water, dried (Na2S04) and evaporated: 
oily material, crystallization from Et 2 0, recrystallization from benzene/pe-
troleum ether: 0.38 g (74%) of 9-1, m.p. 118°C, [a]^ > = -8° (CHC1 3 ).-
C25H28CINO9 (521.9) calc. C 57.5 H 5.41 CI 6.8 found C 57.7 H 5.51 CI 
7.0. 
HPLC-analysis: Si0 2 ; CH 2 Cl2 /Et 2 0 1:4; Altex apparatus, pump 110 A, 
detector Kontron 720 LC, 256 nm, integrator Shimadzu C-R1A, sample 
injector Rheodyne 7125, flow 1.0 ml/min. 
IT (KBr): 1695 (CO), 1760 cm"1 (CO).- MS: m/z = 521 (M+\ 3 5C1, 2%), 
485 (4, *451.49), 418 (3, *335.36), 382 (15, *300.87), 328 (12), 292 (18, 
*259.95), 264 (2), 225 (3), 220 (100), 205 (12, *191.02), 193 (6), 177 (2), 
147 (3), 116 (7).- MS-HR: C 1 2 H 1 4 N 0 3 calc. 220.09732 found 220.09726.-
! H-NMR (90 MHz, 50°C): 8 (ppm) = 1.25 (t; J = 7.0 Hz, 3H, -CH 2-CH 3), 
2.56-2.82 (m; 4H, -CH 2-), 2.74 (s; 3H, -NCH 3), 3.82 (s; 3H, -OCH 3), 4.07 
(s; 3H, -OCH 3), 4.09 (s; 3H, -OCH 3), 4.11 (q of d; J q = 7.0 Hz, J d = 1.0 Hz, 
2H, -CH 2-CH 3), 5.00 (d; J = 9.3 Hz, 1H, -CH-C1), 5.99, 6.03 (AB; J = 1.3 
Hz, 2H, -0-CH 2-0-), 6.11 (dd; J u = 8.4/1.0 Hz, 1H, arom.), 6.28 (d; J = 
9.3 Hz, -CH-0-), 6.40 (s; 1H, arom.), 6.92 (d; J = 8.4 Hz, 1H, arom.).- UV 
(MeOH): A. max (log e) = 214 (4.58), 292 (sh; 3.60), 309 nm (3.66). 
3-{[2-($-N-Ethoxycarbonyl-N-methyl-aminoethyl)-6-m^ 
enedioxy-phenylj-hydroxymethyl} -6,7-dimethoxy-1 (3H )-isobenzofuranone 
(10) 
a) 0.52 g (1 mmole) of 9-1 were refluxed in 20 ml of water for 5 h. After 
cooling and extraction with CHC13, the org. phase was dried (Na2S04) and 
evaporated: colorless oil, crystals from Et 2 0: 0.46 g (91%) of 10, m.p. 
101°C, [a]2g> = -49° (CHC13).- C 2 5 H 2 9 N O 1 0 (503.5) calc. C 59.6 H 5.81 N 
2.8 found C 59.7 H 5.87 N 2.6.- Spectral data are reported by Lee et al. 8 ). 
b) 0.52 g (1 mmole) of 9-1 and 1.2 g (5 mmole) of freshly precipitated 
A g 2 0 were refluxed in dioxan for 24 h. Work-up as described and column 
chromatography (cc) (Si0 2; C H C l ^ ^ O 1:1) afforded colorless crystals, 
identical with compound 10 obtained by procedure a). 
Reconversion of10 to 9-1 
0.50 g (1 mmole) of 10 in 5 ml of absol. CHC13 were stirred with 0.14 g 
(1.2 mmole) of freshly distilled SOCl 2 for 2 h at room temp. The mixture 
was poured into ice water. Extraction (CHC13), drying (Na 2S0 4), evapora-
tion, cc (Si0 2; C H C l ^ ^ O 1:1), and crystallization (Et20) led to 0.48 g 
(92%) of 9-1, m.p. 118°C, [a]2?, = -8° (CHC13). 
Conversion of 9-1 to stiibene 11 (entry 6, Table 1) 
0.10 g (0.2 mmole) of 9-1 in 5 ml of absol. acetone were stirred with 0.30 
g (2 mmole) of Nal at reflux temp, under N 2 for 8 h. After dilution with 
water and extraction (CHC13) stiibene 11 was obtained, identical with auth-
entic material (see below). 
3-[2-($-N-Ethoxycarbonyl-N-methyl-aminoethyl)-6-methoxy-4J-methyl-
enedioxy-benzylidenyl]-6,7-dimethoxy-l(3H)-isobenzofuranon^ll) 
0.52 g (1 mmole) of 9-1 and 0.15 g (1 mmole) of DBU in 10 ml of absol. 
benzene were refluxed for 15 h. After cooling and extraction with 2 N HCl 
the org. phase was dried (Na2S04) and evaporated: yellow oil; purification 
by cc (Si0 2; CHCl3/Et20 1:1) produced crystals, recrystallization from ben-
zene: 0.42 g (86%) of 11, m.p. 170°C- C 2 5 H 2 7 N 0 9 (485.5) calc. C 61.8 H 
5.60 found C 61.7 H 5.65.- IR (KBr): 1695 (CO), 1775 cm"1 (CO).- MS: 
m/z = 485 (M"*, 88%), 467 (1, *449.67), 383 (69), 382 (100, *302.45), 369 
(26), 341 (19, *315.12), 292 (49), 264 (14, *238.68), 193 (58, *97.51), 189 
(10), 116 (97).- JH-NMR: 8 (ppm) = 1.17 (t; J = 7 Hz, 3H, -CHrCIfc), 
2.55-4.10 (m; 6H, -CH 2 - , -CH2-CH 3 ) , 2.76 (s; 3H, -NCH 3), 3.97 (s; 3H, 
-OCH 3), 4.03 (s; 3H, -OCH 3), 4.14 (s; 3H, -OCH 3), 5.92 (s; 2H, -0-CH 2 -0-
), 6.33 (s; 1H, arom.), 6.51 (s; 1H, vinyl-H), 7.30, 7.60 (AB; J = 9 Hz, 2H, 
arom.).- UV (MeOH): X max (log e) = 220 (4.39), 283 (4.10), 355 nm 
(4.11). 
ECF-degradation of (-)-$-narcotine ((-)-6): 3-{[2-($-N-Ethoxycarbonyl-
N-methyl-aminoethyl)-6-methoxy-4J-methylenedioxyphenyl]-chloro-
methyl}-6f7-dimethoxy-l-(3H)-isobenzofuranones (9-III and 9-IV) 
(-)-6 was treated with ECF under the conditions used for the ECF-cleav-
age of (-)-5.- 9-IV was obtained by crystallization from absol. Et20,9-III by 
cc (Si0 2; CHCtyE^O 1:1) and crystallization from Et 2 0. 
9-III: m.p. 123°C, [a]2^ = -7.5° (CHC13) 
9-IV: m.p. 120°C, [a]2?, = +7° (CHC13) 
DBU-catalyzed cleavage of hydroxy-urethan 10 
0.20 g (0.4 mmole) of 10 and 0.12 g (0.8 mmole) of DBU in 5 ml of 
absol. dimethylformamide were heated to 120°C for 24 h. After evaporation 
the residue was suspended in water, the mixture was acidified with 2N HCl 
and extracted with CHC13. The org. phase was dried (Na 2S0 4) and evap-
orated, the remaining oil was purified by cc (SiO^, CHCiyE^O 1:1). Me-
conine (14) was obtained from that oil by sublimation (160°C/1 Torr) and 
crystallized from EtOH/water.- The aldehyde 13 crystallized from 
Et20/water. 
14: 0.055 g (71%), m.p. 101°C, li t . 1 9 ) : 102°C- IR (KBr): 1740 cm"1 
(CO).- MS: m/z = 194 (M+", 100%), 176 (61, *159.67), 165 (94, * 140.34), 
163 (16, *136.95), 148 (22, *124.45), 147 (62, *122.78).- ! H-NMR: 8 (ppm) 
= 4.01 (s; 6H, -OCH 3), 5.17 (s; 2H, -CH 2-), 7.13 (s; 1H, arom.), 7.20 (s; 1H, 
arom.). 
2-($-N-Ethoxycarbonyl-N-methyl-aminoethyl)-6-methoxy-
4J5-methylenedioxybenzaldehyde (13) 
Yield 0.04 g (32%), m.p. 103°C, lit . 1 7 ) : 104°C- IR (KBr): 1680 cm"1 
(CO, CHO).- MS: m/z = 309 (M*\ 3%), 291 (14, *274.05), 263 (2), 236 (6), 
206 (80, *137.33), 193 (7), 116 (100). 
Cleavage of10 with p-toluenesulfonic acid 
0.10 g (0.2 mmole) of 10 and 0.017 (g (0.1 mmole) of p-toluenesulfonic 
acid in 10 ml of absol. CH 2 Cl2 were stirred at room temp, for 48 h. The 
solution was washed with 5% KOH, the org. phase was dried (Na2S04) and 
evaporated. From the remaining oil meconine (14) was obtained as de-
scribed above. 
2-(2-Hydroxymethyl-3,4-dimethoxyphenyl)-l-[2-($-N fl-dimethylamino-
ethyl)~6-methoxy-4 J-methylenedioxylphenyl]-ethan-l 2-diol4XS) 
1.50 g (3 mmole) of 10, dissolved in 50 ml of absol. THF, were added 
dropwise to 0.11 g (3 mmole) of L i A l H 4 in 5 ml absol. THF at 0°C. After 
stirring for 3 h excess of LiAlH4 was destroyed by water. A saturated 
solution of NH4CI was added drop by drop under vigorous shaking until 
the precipitate massed together. The org. phase was decanted, the precipi-
tate was extracted several times with CH2CI2. The org. phases were dried 
(Na 2S0 4) and evaporated: colorless oil of 15; 1.20 g (89%), [OC]2D = -69° 
(CHCI3).- C 2 3 H 3 1 N 0 8 (449.4).- IR (KBr): 3400 cm"1 (broad; OH).- 1 H -
NMR: 8 (ppm) = 2.13 (s; 6H, -NCH 3), 2.20-3.70 (m; 4H, -CH 2-), 3.82 
(s; 9H, -OCH3), 4.58 (s; 2H, -CHrOH), 5.07, 5.27 (AB; J = 9 Hz, 2H, 
-CÜ-OH), 5.85 (s; 2H, -0-CH 2-0-), 6.27 (s; 1H, arom.), 6.75, 7.03 (AB; J 
= 9 Hz, 2H, arom.).- UV (MeOH): X max (log e) = 228 (4.39), 283 nm 
(3.57). 
4-Hydroxy-7,8-dimethoxy-3-[2-(p-NJ^-dimethyl-aminoethyl)-6-methoxy-
4£-methylenedioxyphenyl]-isochroman(16) 
0.22 g (0.5 mmole) of 15 were refluxed in 2 N HCl for 2 h. After cooling 
the solution was adjusted to pH 8.5 by NaHC0 3 and extracted with CHC13. 
The org. phase was dried (Na2S04) and evaporated. The oily material was 
purified by cc (A1 20 3, AcOEt) affording a colorless oil, which slowly 
crystallized from Et 2 0: 0.17 g (79%) of 16, m.p. 88°C, [a]2g> = +9° 
(CHC13).- C23H29N(>7 (431.5).- IR (KBr): 3400 cm"1 (broad; OH).- MS: 
m/z = 413 (100%), 368 (12), 337 (7).- ^ - N M R (90 MHz): 8 (ppm) = 2.15, 
2.22 (2 x s; 6H, -NCH 3), 2.28-2.60 (m; 4H, -CH 2-), 3.81, 3.83, 3.85, 3.91, 
3.96 (5 x s; 9H, -OCH 3), 5.14, 5.37 (AB; J = 13.4 Hz, 2H, -CH 2-0-), 5.30 
(s), 5.79 (s), 5.92 (s; -CH-0-), 5.93,5.95 (AB; J = 1.4 Hz, 2H, -0-CH 2-0-), 
6.27, 6.66 (AB; J = 8.3 Hz, arom. H), 6.38, 6.49, 6.55, 6.73, 6.75 (AB, s; 
arom. H) (all together 3H, arom.).- ^ - N M R (60 MHz, d6-benzene): 8 
(ppm) = 2.05; 2.15 (2 x s; 6H, -NCH 3), 3.27, 3.33 (2 x s; 3H, -OCH 3), 3.55, 
3.60 (2 x s; 3H, -OCH 3), 3.73, 3.82 (2 x s; 3H, -OCH 3).- UV (MeOH): X 
max (log e) = 288 nm (4.00). 
ECF-Degradation of a-narcotine Na-salt 
0.45 (1 mmole) of 5-Na-salt12) were treated with ECF as described for 5 
(vide supra).- The oil so obtained was separated by cc (Si0 2; C H C l ^ ^ O 
1:1). 
fraction 1: chloro-urethan 9-1 (0.23 g, 44%) 
fraction 2: hydroxy-urethan 10 (0.25 g, 50%) 
ECF-Degradation of$-hydrastine (7): 3-[2-($-Ethoxycarbonyl-N-methyl-
aminoethyl)-4J5-methylenedioxy-benzylidenyl]-6,7-dimethoxy-l(3H)-
isobenzofuranone (17), 3-{[2-($-N-Ethoxycarbonyl-N-methyl-aminoethyl)-
4J-methylenedioxyphenyl]-chloromethyl}-6,7-dimethoxy-l(3H)-isote 
furanone (18), and 3-{[2-($-N-Ethoxycarbonyl-N-methylaminoethyl)-
4 J-methylene- dioxyphenylj-methoxymethyl} -6,7-dimethoxy-
l(3H)-isobenzofuranone (19) 
0.38 g (1 mmole) of 7 were treated with ECF as described for a-narco-
tine (5).- The crystals obtained after usual work-up were suspended in a 
few ml of Et 2 0 and filtered: 17: 0.19 g (42%), m.p. 147-148°C-
C^H^NOg (455.5) calc. C 63.3 H 5.53 found C 63.5 H 5.43.- IR (KBr): 
1690 (CO), 1775 cm"1 (CO).- MS: m/z = 455 (M+*, 68%), 352 (100, 
*272.32), 337 (20), 311 (26), 262 (16), 193 (29), 116 (61).- ^ - N M R : 8 
(ppm) = 1.27 (t; J = 7 Hz, 3H, -CH 2-CH 3), 2.80-4.33 (m; 6H, -CH-, 
-CH2-CH 3 ) , 2.90 (s; 3H, -NCH 3), 3.99 (s; 3H, -OCH 3), 4.17 (s; 3H, -
OCH 3), 6.00 (s; 2H, -0-CH 2-0-), 6.72 (s; 1H, vinyl-H), 6.83-7.80 (m; 4H, 
arom.).- UV (MeOH): X max (log £) = 223 (4.33), 242 (sh; 4.26), 305 
(4.04), 378 nm (4.18).- Evaporation of the etheral solution (vide supra) led 
to crystals containing stilbene 17 and the chloromethyl derivative 18 (4:1). 
18: C24H26C1N08 (491.9).- IR (KBr): 1680 (CO), 1780 cm"1 (CO).- MS: 
m/z = 491 (M+\ 3 5C1, 2%), 455 (37, *421.64), 446 (2), 410 (2), 388 (15), 
352 (48, *272.32), 339 (17), 311 (12), 298 (41), 262 (23, *230.35), 193 
(43), 116 (100).- MS-HR: C^H^ClNOg: calc. 491.13470 found 
491.13579.- JH-NMR: 8 (ppm) = 1.28 (t; J = 7 Hz, 3H, -CH 2-CH 3), 2.57-
4.00 (m; 5H, -CH 2 - , -CH-C1), 2.88 (s; 3H, -NCH 3), 3.92 (s; 3H, -OCH 3), 
4.08 (s; 3H, -OCH 3), 4.18 (q; J = 7 Hz, 2H, - C H r C H ^ , 5.63 (s; br., 1H, 
-0-CH-), 5.97 (s; 2H, -0-CH 2-0-), 6.60-7.47 (m; 4H, arom.).- UV 
(MeOH): A. max (qual.) = 219; 242 (sh); 298 nm. 
Analytical HPLC (RP 18; MeOH/water 3:1 and Si 60; CH 2 Cl2 /Et 2 0 4:1) 
indicated that 18 is converted to the methoxymethyl derivative 19 by 
MeOH. 19 was isolated by prep. HPLC (RP 18, MeOH/water 3:1): color-
less oil. 
19: C25H29N09 (487.5).- IR (film): 1690 (CO), 1760 cm"1 (CO).- MS: 
m/z = 445 (1%), 410 (6), 294 (100), 262 (92, *233.48), 234 (32, *208.99).-
^ - N M R : 8 (ppm) = 1.30 (t; J = 7 Hz, 3H, -CHrOfc), 2.47-4.00 (m; 5H, 
-CH 2 - , -0-CH-), 2.92 (s; 3H, -NCH 3), 3.37 (s; 3H, -CH-OCH 3), 3.93 (s; 
3H, -OCH 3), 4.08 (s; 3H, -OCH 3), 4.20 (q; J = 7 Hz, 2H, -CÜ2-CH 3), 5.57 
(d; J = 6 Hz, 1H, -0-CH-), 6.02 (s; 2H, -0-CH 2-0-), 6.67,7.22 (AB; J = 9 
Hz, 2H, arom.), 6.73 (s; 1H, arom.), 6.83 (s; 1H, arom.).- UV (MeOH): X 
max (log e) = 242 (sh; 3.69), 288 nm (3.26). 
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